Demand for Fertility Supplements in EU is expected to surge from USD 250.00 Million in 2025 to USD 559.60 Million by 2036, reflecting a CAGR of 7.6%. Vitamins & Minerals will account for a 50.0% product type share, while Tablets is poised to lead the form segment.